#HCG 🧵to provide key technical analysis insight & learning through one of popular stock HCG (valid for long term investors & traders)
Please note there are no GOD rules in technical analysis, but discipline makes a rule GOD for us when transactions go for a toss
Keep reading..
Let us focus on 2 things: 1. Why as an investor I start any chart reading with monthly chart for longer term direction
2. Why relative performance matters
1. Importance of monthly charts: peaceful investing without much churn in portfolio and daily tracking (this is one of the ways, not the only way or best way to take decisions).
a. Exit: If one would have simply plotted relative performance with respect to NIFTY, he would
have got out in early 2018 and avoided whole decline and underperformance for next 2 years
b. Entry: Further, in June 2020, would have taken entry based on outperformance to NIFTY and would have continued to outperform NIFTY
c. Average up: Whenever stocks relative performance came at par with NIFTY, it created a temporary bottom and next leg of run from there
2. Why relative performance matters:
NIFTY return itself has been respectable 12-14% over long term and if one can outperform this without much fuss and peace of mind with lesser churn, not a bad idea. Relative strength performance analysis helps to ideate the same
Currently, HCG has started underperforming NIFTY though not by a heavy margin but for last few months unless last few times when it rebounded quickly. No one will know the future but it is all about discipline of well tested rules which a protection cover to save from big falls
and ride big gains.
So, this was all about blending 2 concepts - relative strength and longer timeframes to simplify some of the concepts.
At Scientific Investing, we love to teach many such concepts and will be teaching in detail through our CMT level study sessions and much more in our practitioner membership. You can explore the same here. learn.scientificinvesting.in/learn/SI-PRACT…
Also, we love to teach about rule building, quantification, back testing, building systems and algorithms picking such ideas in our QUANTS learning track. You can explore it here. learn.scientificinvesting.in/learn/QUANTECH
Like and share if this was useful for wider reach🙏
Remember the key message - Its not about predicting a perfect buy or sell call or trying to predict HCG ka kya hoga. The key message is bigger and about patterns/rules/discipline and systems - focus there
Also, think more, conclude less - Killing all this analysis above - Why it looked so beautiful - because either the stock was in continuous uptrend or downtrend. The moment it goes no where for month doing criss cross, the rule may become pain in the ass which means it needs
more thoughts. Think about it. My goal is only to make you think and not talk about what will happen to HCG or what a great or crappy rule is this. There is nothing perfect but there are always better solutions n possibility for improvement
• • •
Missing some Tweet in this thread? You can try to
force a refresh
#IEX Fundamentals, Technical and the other data, a🧵:
IEX has been coming up with great results but market is anticipating coupling fear and hence stock is falling. This is the common perception.
Is this the case, let us deep dive?
Was curious to check which institutions are selling because if I blindly look at charts - then all we see is stoploss. Something very interesting came out. First thing, looking at screener, looks like FIIs and DIIs are buying and retail is selling. Also, evident in falling count of retail investors. So, who is moving the prices down?
Such a market cap stock can be moved up or down only by institutions. Given FII data is quarterly available but mutual fund data is monthly available, looked at the mutual fund data and here is the interesting stuff
An 18–20-page conference call the beginning of the year getting compressed to 10 page at the end of the year with growth stagnating and a 50 PE valuation biting the dust - ER&D is also not secular.
If last 3 cycles of Tata Elxsi did not teach it, let Onward technology 1st cycle teach it #ScientificInvesting
Is it end of new beginning?
Some positives and some negatives from the concall covered in this thread
For Chemicals Sector, based on Q1FY25 result:
❓Best performing chemical companies?
❓Attractively valued chemical companies?
❓Both attractively valued and best performing?
🧵to answer all such questions to help to filter interesting ideas for research
Current price performance:
Last 5 year numbers say it all - a mere 5.5% annualized returns failing to beat FD.
Ask guys 5 years back, how was HDFC treated in market then
Given stock has not given good returns, it is important to understand if stock performed badly earnings wise in last 5 years. Nothing changed in last 5, 3, 1 year.
Is the future going to be different and is stock going to underperform big time on growth?
HDFC Bank (keeping merger aside) has added employes and branches at 22-24% growth rate in FY23 vs FY22.
Conference calls r best way to understand business. 💡10 Key #ConcallInsights #Intellectdesign #Q2FY24
💡What excites: A software business with high growth prospects of 15-20% topline growth and higher PAT growth
💡 Some unique aspects of software business. The development to sales cycle of software business explained (we discussed this at length during our IT supersession).
💡 8 out of 12 products are in the leadership quadrant of global technology analysts like Gartner, Celent etc. Says about the strength of software business (software is a differentiated business compared to services, discussed at length in our supersession)